In earlier reports, most patients carried mutations in paroxysmal dyskinesia-specific genes such as PRRT2, PNKD and SLC2A1, typically associated with isolated phenotypes and favourable treatment responses. The gene discussed is SLC2A1; the disease is paroxysmal dyskinesia.